Previous 10 | Next 10 |
The precipitous cost decline of next-generation DNA sequencing has supercharged our understanding of tumor biology. The strange biology that makes it dangerous also gives scientists the opportunity to detect cancer earlier. The exponential cost declines associated with NGS, AI, an...
Philippe Laffont’s 13F portfolio value increased from $18.24B to $25.52B this quarter. Coatue Management increased Amazon.com, Moderna, Twilio, and Peloton Interactive while decreasing XPeng and dropping Farfetch Limited. The largest three positions are DoorDash, Amazon.com...
REDWOOD CITY, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating virtually in the upcoming Morgan Stanley Global Healthcare Conference. Guardant Health’s manageme...
According to a recent report, the global Precision Medicine Market is set to grow beyond $112 billion by 2027. Guardant’s Q2 revenues grew 39% over the year to $92.1 million, ahead of the Street’s forecast by 8.8%. By segment, revenues from Precision oncology grew 42...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the upcoming UBS Genomics 2.0 and MedTech Innovations Summit. Guardant Health’s management is scheduled to participate in a fireside chat on Tuesday,...
Image source: The Motley Fool. Guardant Health, inc (NASDAQ: GH) Q2 2021 Earnings Call Aug 5, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Guardant Health, inc (GH) Q2 2021 Earnings Call Transcript
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Illumina’s (NASDAQ: ILMN ) strong growth and tremendous potential make ILMN stock worth buying. Source: Shutterstock It’s true that the company’s shares are not at all cheap. Still, the dema...
Guardant Health, Inc. (GH) Q2 2021 Earnings Conference Call August 5, 2021 4:30 PM ET Company Participants Carrie Mendivil – Investor Relations Helmy Eltoukhy – Chief Executive Officer AmirAli Talasaz – President Mike Bell – Chief Financial Officer Conference Call ...
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Mega cap growth stocks that have traded together and driv...
Baron is an asset management firm focused on delivering growth equity investment solutions known for long-term, fundamental, active approach to growth investing. Baron Asset Fund increased 10.03% (Institutional Shares), while the Russell Midcap Growth Index increased 11.07%, and the S...
News, Short Squeeze, Breakout and More Instantly...
Shield is first blood test approved by FDA as a primary screening option for colorectal cancer and that meets performance requirements for Medicare coverage Blood test offers easy, convenient and pleasant screening option with potential for improving colorectal cancer screening rates ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the second quarter 2024 after market close on Wednesday, August 7, 2024. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Ti...
Running on Guardant Infinity™ smart liquid biopsy platform, new Guardant360 test covers over 10 times more genes, including all guideline-recommended genomic biomarkers across advanced solid tumors, and quantifies tumor burden with 10 times higher sensitivity Upgraded test covered ...